Long-Term Cumulative High-Sensitivity Cardiac Troponin T and Mortality Among Patients with Acute Heart Failure
Authors:
Open Access
- 3 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 10 (3) , 1781-1792
Abstract
Aims: This study aimed to evaluate the cumulative high-sensitivity cardiac troponin T (hs-cTNT) from admission to 12 months after discharge and its association with mortality after 12 months among patients with acute heart failure (HF). Methods: We used data from the China Patient-Centered Evaluative Assessment of Cardiac Events Prospective Heart Failure Study (China PEACE 5p-HF Study), which enrolled patients hospitalized primarily for HF from 52 hospitals between 2016 and 2018. We included patients who survived within 12 months and had hs-cTNT data at admission (within 48 h of admission) and 1 and 12 months after discharge. To evaluate the long-term cumulative hs-cTNT, we calculated cumulative hs-cTNT levels and cumulative times of high hs-cTNT level. Patients were divided into groups according to the quartiles of cumulative hs-cTNT levels (Quartiles 1–4) and cumulative times of high hs-cTNT levels (0–3 times). Multivariable Cox models were constructed to examine the association of cumulative hs-cTNT with mortality during the follow-up period. Results: We included 1137 patients with a median age of 64 [interquartile range (IQR), 54–73] years; 406 (35.7%) were female. The median cumulative hs-cTNT level was 150 (IQR, 91–241) ng/L*month. Based on the cumulative times of high hs-cTNT levels, 404 (35.5%) patients were with zero time, 203 (17.9%) with one time, 174 (15.3%) with two times, and 356 (31.3%) with three times. During a median follow-up of 4.76 (IQR, 4.25–5.07) years, 303 (26.6%) all-cause deaths occurred. The increasing cumulative hs-cTNT level and cumulative times of high hs-cTNT level were independently associated with excess all-cause mortality. Compared with Quartile 1 group, Quartile 4 had the highest hazard ratio (HR) of all-cause mortality [4.14; 95% confidence interval (CI): 2.51–6.85], followed by Quartile 3 (HR: 3.35; 95% CI: 2.05–5.48) and Quartile 2 (HR: 2.47; 95% CI: 1.49–4.08) groups. Similarly, taking the patients with zero time of high hs-cTNT level as the reference, the HRs were 1.60 (95% CI: 1.05–2.45), 2.61 (95% CI: 1.76–3.87), and 2.86 (95% CI: 1.98–4.14) in patients who had one, two, and three times of high hs-cTNT level, respectively. Conclusions: Elevated cumulative hs-cTNT from admission to 12 months after discharge was independently associated with mortality after 12 months among patients with acute HF. Repeated measurements of hs-cTNT after discharge may help monitor the cardiac damage and identify patients with high risk of death.Keywords
Funding Information
- China Academy of Chinese Medical Sciences Innovation Fund for Medical Science (2021-I2M-1-009)
- National key research and development program (2018YFC1312400)
- National Key Technology R&D Program (2015BAI12B02)
- National Key Research and Development Program of China (2018YFC1312400)
- National Science and Technology Infrastructure Program (2015BAI12B02)
This publication has 32 references indexed in Scilit:
- The vulnerable phase after hospitalization for heart failureNature Reviews Cardiology, 2015
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatmentEuropean Heart Journal, 2013
- Troponin I in Acute Decompensated Heart Failure: Insights from the ASCEND-HF StudyEuropean Journal of Heart Failure, 2012
- Cardiac troponin and heart failure in the era of high-sensitivity assaysJournal of Cardiology, 2012
- Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure SectionEuropean Heart Journal, 2012
- Prevalence of chronic kidney disease in China: a cross-sectional surveyThe Lancet, 2012
- Troponin Elevation in Heart FailureJACC, 2010
- A Validated Risk Score for In-Hospital Mortality in Patients With Heart Failure From the American Heart Association Get With the Guidelines ProgramCirculation: Cardiovascular Quality and Outcomes, 2010
- Cardiac Troponin and Outcome in Acute Heart FailureNew England Journal of Medicine, 2008
- Modified Glomerular Filtration Rate Estimating Equation for Chinese Patients with Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2006